Physician profile
Katrina Oconnor
NPI 1033657267
$1,374.62
in general payments reported to CMS, 2019-2025
18 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $897 · 2022: $142 · 2023: $60.53 · 2024: $136 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $332.08 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $174.88 | 2021-2024 | Airsupra |
| Amgen INC. | $155.95 | 2021 | |
| Novo Nordisk INC | $123.08 | 2021-2025 | Ozempic |
| Dexcom, INC. | $106.83 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Boston Scientific Corporation | $86.59 | 2021 | |
| Lilly USA, LLC | $78.34 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.95 | 2021-2023 | |
| Amarin Pharma, INC. | $47.76 | 2021 | |
| Medtronic, INC. | $39.14 | 2023 | Corevalve Evolut R |
| Esperion Therapeutics, INC. | $37.56 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $24.36 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.43 | 2021 | |
| Abbott Laboratories | $19.86 | 2021 | |
| Merck Sharp & Dohme LLC | $17.47 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $15.45 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.96 | 2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Oconnor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.